ABIVAX Société Anonyme reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 4.6 million compared to EUR 4.6 million a year ago. Net loss was EUR 147.4 million compared to EUR 60.7 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.38 EUR | -0.59% | -4.84% | +36.25% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.25% | 907M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- ABVX Stock
- News Abivax
- ABIVAX Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023